veronapharma.com (VRNA): Operating Profitability

Public company logo of Verona Pharma PLC (VRNA)

The operating margin time series illustrates Verona Pharma plc (VRNA) transitioning toward scaling Ohtuvayre sales following the completion of costly research, with the metric currently standing at -25.20. A risk mitigation strategy leveraging partnerships with leading pulmonologists, combined with inelastic demand for medical care, provides the company with resilience against any economic fluctuations.

VRNA: Verona Pharma PLC Operating Margin 07/04/2022 - 10/18/2025

Verona Pharma plc (VRNA) - metric breakdowns and financial figures

- price and consensus price forecast:
- stock exchange capitalization data:
Fundamental company valuation:Verona Pharma PLC, VRNA
Core merchandise of Verona Pharma Inc.

For Verona Pharma plc (VRNA), the success of commercializing respiratory drugs is directly determined by the cost efficiency of production in the US and UK. The operating margin, calculated as the ratio of operating income to revenue, demonstrates the share of net income from every dollar earned before accounting for financial obligations. By analyzing the operating margin chart, an investor can promptly identify hidden business degradation and avoid a value trap.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Margin MENS|Ligand Pharmaceuticals - Return on Sales by Operating Profit|Operating Profitability Amneal AMRX|Operating Profitability Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Operating Margin|Profitability of Operations Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operating Profitability|anipharmaceuticals.com - Operating Profit Rate|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.